Navigation Links
Identical Genes From Parents May Raise Cancer Risk
Date:3/25/2008

Finding could someday aid in diagnosis, treatment, experts say

TUESDAY, March 25 (HealthDay News) -- People who have two identical copies of certain genes -- one inherited from the mother and one from the father -- seem to be at greater risk of developing a number of common types of cancer, research shows.

Although the findings need to be validated in more studies, there could be significant implications for patient care, experts say.

"This could represent a new way to do cancer risk-assessment. I suspect this will be added into routine clinical testing," said Dr. Charis Eng, senior author of the paper published in the March 26 issue of the Journal of the American Medical Association. "This is truly 'genetics to keep healthy people healthy,' " she said.

Eng, who is director of the Genomic Medicine Institute at the Cleveland Clinic Foundation, noted that by the time such tests wind their way into clinical practice, doctors should also have more preventative and screening tools at their disposal.

Unlike many currently available genetic tests -- such as those for the BRCA1 and 2 genes thought to play a role in breast cancer -- these anticipated tests could be applicable to everybody, not just people at high risk for a particular malignancy.

Similarly, the new findings suggest that more than 5 percent of all cancers are linked to heredity, the researchers said.

Previously, Eng had noticed that a high level of germline cells (those containing genetic material that can be passed on to children) were homogenous, meaning that two copies of the same gene were identical. Her team was studying heterozygosity, but these cells were "maddeningly homogenous," she said. At first, she attributed the pattern to bad luck, but after years of finding the same thing, she decided it couldn't be a coincidence.

So, Eng and her colleagues decided to look at 400 genetic markers scattered throughout the genome in 385 breast, prostate and head and neck cancer patients and in people without cancer.

All patients were of the same ethnic group.

"Lo and behold, in 16 markers, let's call them 'hot spots,' there were high frequencies of homozygosity compared to the controls," Eng said.

The association was then validated in patients with lung cancer. This time, they streamed through 250,000 markers across the human genome and found that cancer patients were more likely to have homozygosity in the same 16 markers.

"We are saying that lack of genetic diversity or uniformity in hot spots in 16 places seems to be associated with common cancers," Eng said. "This is a novel means of cancer predisposition."

"We don't know the mechanism yet," she added. "Right now, it's an association."

The study authors have postulated that this homozygosity occurs at "common" fragile sites on the genome, sites that are susceptible to DNA damage. These are to be distinguished from "rare" fragile sites that are also sensitive to such damage but are more likely to be associated with less common cancers.

More information

For more on different types of cancer, visit the U.S. National Cancer Institute.



SOURCES: Charis Eng, M.D., Ph.D., director, Genomic Medicine Institute, Cleveland Clinic Foundation; March 26, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Warns Against Bio-Identical Hormone Therapy
2. FDA Asserts New Policy to Restrict Womens Access to Bioidentical Hormones
3. Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal
4. Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
5. Genes that protect against atherosclerosis identified
6. Genesis Pharmaceuticals Changes Auditors
7. Cell Genesys to Present at the Cowen and Company and the Lehman Brothers Healthcare Investor Conferences
8. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
9. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
10. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
11. Cell Genesys Reports Fourth Quarter and Year-End 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Identical Genes From Parents May Raise Cancer Risk
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, ... 30th and 31st at The Four Seasons Hotel Boston. , The Boston ... sciences, offering exclusive access to key decision makers who influence deal making and ...
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a leading ... sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a ... operations. With this platform, initializing devices and importing studies are just one-click operations. ...
(Date:5/26/2017)... ... May 26, 2017 , ... via seating ... mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh ... to partner with Cupron® to provide customers with a game changing chair that ...
(Date:5/26/2017)... Abilene, Texas (PRWEB) , ... May 26, 2017 , ... ... released a new publication this week that is focusing on the Peace Agreements being ... begun his Middle East sprint in a race to try to speed up peace ...
(Date:5/26/2017)... ... ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in wisdom teeth extraction ... options. If a Bay Area patient has to search for a second opinion before ... in-network provider for a second opinion can ensure a patient receives the full benefits ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
Breaking Medicine Technology: